Ron Bentsur - 18 Aug 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
18 Aug 2022
Net transactions value
+$168,725
Form type
4
Filing time
22 Aug 2022, 09:00:39 UTC
Previous filing
16 Aug 2022
Next filing
30 Aug 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $123,775 +14,426 +0.48% $8.58 3,002,409 18 Aug 2022 Direct F1, F2
transaction NVCT Common Stock Purchase $44,950 +5,000 +0.17% $8.99 3,007,409 19 Aug 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average purchase price. The range of prices for the shares purchased was $8.55 to $8.60. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Includes 96,759 shares of restricted stock and 120,000 restricted stock units.